These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 22987560

  • 1. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M, Christensen RK, Ørnskov D.
    Cancer Cytopathol; 2013 Mar; 121(3):136-45. PubMed ID: 22987560
    [Abstract] [Full Text] [Related]

  • 2. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM.
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [Abstract] [Full Text] [Related]

  • 3. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group.
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [Abstract] [Full Text] [Related]

  • 4. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
    Wentzensen N, Fetterman B, Tokugawa D, Schiffman M, Castle PE, Wood SN, Stiemerling E, Poitras N, Lorey T, Kinney W.
    Cancer Cytopathol; 2014 Dec; 122(12):914-20. PubMed ID: 25132656
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions.
    Ziemke P, Marquardt K, Griesser H.
    Acta Cytol; 2014 Dec; 58(5):489-94. PubMed ID: 25342512
    [Abstract] [Full Text] [Related]

  • 6. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J.
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS.
    Int J Med Sci; 2013 Nov; 10(12):1602-7. PubMed ID: 24151431
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, Hwang JSG, Mantoo S.
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [Abstract] [Full Text] [Related]

  • 10. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 11. Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.
    Gilbert L, Ratnam S, Jang D, Alaghehbandan R, Schell M, Needle R, Ecobichon-Morris A, Wadhawan A, Costescu D, Elit L, Wang P, Zahariadis G, Chernesky M.
    Cancer Biomark; 2022 May 15; 34(3):347-358. PubMed ID: 35001877
    [Abstract] [Full Text] [Related]

  • 12. CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings.
    Ratnam S, Jang D, Gilbert L, Alaghehbandan R, Schell M, Needle R, Ecobichon-Morris A, Wang PP, Rahman M, Costescu D, Elit L, Zahariadis G, Chernesky M.
    Papillomavirus Res; 2020 Dec 15; 10():100206. PubMed ID: 32828968
    [Abstract] [Full Text] [Related]

  • 13. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
    Donà MG, Vocaturo A, Giuliani M, Ronchetti L, Rollo F, Pescarmona E, Carosi M, Vocaturo G, Benevolo M.
    Gynecol Oncol; 2012 Aug 15; 126(2):198-202. PubMed ID: 22588180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.
    Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168
    [Abstract] [Full Text] [Related]

  • 16. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Liu W, Gong J, Xu H, Zhang D, Xia N, Li H, Song K, Lv T, Chen Y, Diao Y, Jao J, Dai S, Zhao P, Yao Q.
    Diagn Cytopathol; 2020 Jul 01; 48(7):635-644. PubMed ID: 32275355
    [Abstract] [Full Text] [Related]

  • 17. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.
    Acta Cytol; 2012 Jul 01; 56(5):506-14. PubMed ID: 23075891
    [Abstract] [Full Text] [Related]

  • 18. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E.
    Gynecol Oncol; 2011 Apr 01; 121(1):49-53. PubMed ID: 21194734
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M, Clad A, von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, Griesser H, Freudenberg N, von Knebel Doeberitz M.
    Gynecol Oncol; 2010 Oct 01; 119(1):98-105. PubMed ID: 20619445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.